APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Thrombin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Topical Thrombin Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchTopical Thrombin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Thrombin Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Topical Thrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Thrombin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Thrombin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Topical Thrombin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Thrombin include Takeda, Shanghai RAAS, Pfizer, Hualan Biological, Bayer, Omrix Biopharmaceuticals, Octapharma, Haematologic Technologies and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Topical Thrombin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Topical Thrombin market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Topical Thrombin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Topical Thrombin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Topical Thrombin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Topical Thrombin Market by Company

Takeda

Shanghai RAAS

Pfizer

Hualan Biological

Bayer

Omrix Biopharmaceuticals

Octapharma

Haematologic Technologies

Grifols

GE Healthcare

CSL

Topical Thrombin Segment by Type

Based Bovine

Based Human

Others

Topical Thrombin Segment by Application

Academic and Research Institute

Hospitals

Diagnostics & Clinics

Topical Thrombin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Thrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Thrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Thrombin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Topical Thrombin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Topical Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Based Bovine Table 2. Major Company of Based Human Table 3. Major Company of Others Table 4. Global Topical Thrombin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Topical Thrombin Sales by Type (2021-2026) & (tons) Table 6. Global Topical Thrombin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Topical Thrombin Sales Market Share in Value by Type (2021-2026) Table 9. Global Topical Thrombin Price by Type (2021-2026) & (US$/kg) Table 10. Global Topical Thrombin Sales by Type (2027-2032) & (tons) Table 11. Global Topical Thrombin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Topical Thrombin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Topical Thrombin Sales Market Share in Value by Type (2027-2032) Table 14. Global Topical Thrombin Price by Type (2027-2032) & (US$/kg) Table 15. North America Topical Thrombin Sales by Type (2021-2026) & (tons) Table 16. North America Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Topical Thrombin Sales by Type (2021-2026) & (tons) Table 18. Europe Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Topical Thrombin Sales by Type (2021-2026) & (tons) Table 20. Asia-Pacific Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Topical Thrombin Sales by Type (2021-2026) & (tons) Table 22. Latin America Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Topical Thrombin Sales by Type (2021-2026) & (tons) Table 24. Middle East and Africa Topical Thrombin Sales by Type (2021-2026) & (US$ Million) Table 25. Topical Thrombin Industry Trends Table 26. Topical Thrombin Industry Drivers Table 27. Topical Thrombin Industry Opportunities and Challenges Table 28. Topical Thrombin Industry Restraints Table 29. Global Topical Thrombin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Topical Thrombin Revenue Market Share by Company (2021-2026) Table 31. Global Topical Thrombin Sales by Company (2021-2026) & (tons) Table 32. Global Topical Thrombin Sales Share by Company (2021-2026) Table 33. Global Topical Thrombin Market Price by Company (2021-2026) & (US$/kg) Table 34. Global Topical Thrombin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Topical Thrombin Major Company Production Sites and Headquarters Table 36. Global Topical Thrombin Company, Product Type & Application Table 37. Global Topical Thrombin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Topical Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Topical Thrombin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Topical Thrombin Sales by Region (2021-2026) & (tons) Table 42. Global Topical Thrombin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Topical Thrombin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Topical Thrombin Sales Market Share in Value by Region (2021-2026) Table 45. Global Topical Thrombin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Global Topical Thrombin Sales by Region (2027-2032) & (tons) Table 47. Global Topical Thrombin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Topical Thrombin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Topical Thrombin Sales Market Share in Value by Region (2027-2032) Table 50. Global Topical Thrombin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 51. Global Topical Thrombin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Topical Thrombin Sales by Application (2021-2026) & (tons) Table 53. Global Topical Thrombin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Topical Thrombin Sales Market Share in Value by Application (2021-2026) Table 56. Global Topical Thrombin Price by Application (2021-2026) & (US$/kg) Table 57. Global Topical Thrombin Sales by Application (2027-2032) & (tons) Table 58. Global Topical Thrombin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Topical Thrombin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Topical Thrombin Sales Market Share in Value by Application (2027-2032) Table 61. Global Topical Thrombin Price by Application (2027-2032) & (US$/kg) Table 62. North America Topical Thrombin Sales by Application (2021-2026) & (tons) Table 63. North America Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Topical Thrombin Sales by Application (2021-2026) & (tons) Table 65. Europe Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Topical Thrombin Sales by Application (2021-2026) & (tons) Table 67. Asia-Pacific Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Topical Thrombin Sales by Application (2021-2026) & (tons) Table 69. Latin America Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Topical Thrombin Sales by Application (2021-2026) & (tons) Table 71. Middle East and Africa Topical Thrombin Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Takeda Topical Thrombin Product Portfolio Table 76. Takeda Recent Development Table 77. Shanghai RAAS Company Information Table 78. Shanghai RAAS Business Overview Table 79. Shanghai RAAS Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Shanghai RAAS Topical Thrombin Product Portfolio Table 81. Shanghai RAAS Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Pfizer Topical Thrombin Product Portfolio Table 86. Pfizer Recent Development Table 87. Hualan Biological Company Information Table 88. Hualan Biological Business Overview Table 89. Hualan Biological Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Hualan Biological Topical Thrombin Product Portfolio Table 91. Hualan Biological Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Bayer Topical Thrombin Product Portfolio Table 96. Bayer Recent Development Table 97. Omrix Biopharmaceuticals Company Information Table 98. Omrix Biopharmaceuticals Business Overview Table 99. Omrix Biopharmaceuticals Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Omrix Biopharmaceuticals Topical Thrombin Product Portfolio Table 101. Omrix Biopharmaceuticals Recent Development Table 102. Octapharma Company Information Table 103. Octapharma Business Overview Table 104. Octapharma Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Octapharma Topical Thrombin Product Portfolio Table 106. Octapharma Recent Development Table 107. Haematologic Technologies Company Information Table 108. Haematologic Technologies Business Overview Table 109. Haematologic Technologies Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. Haematologic Technologies Topical Thrombin Product Portfolio Table 111. Haematologic Technologies Recent Development Table 112. Grifols Company Information Table 113. Grifols Business Overview Table 114. Grifols Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. Grifols Topical Thrombin Product Portfolio Table 116. Grifols Recent Development Table 117. GE Healthcare Company Information Table 118. GE Healthcare Business Overview Table 119. GE Healthcare Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 120. GE Healthcare Topical Thrombin Product Portfolio Table 121. GE Healthcare Recent Development Table 122. CSL Company Information Table 123. CSL Business Overview Table 124. CSL Topical Thrombin Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 125. CSL Topical Thrombin Product Portfolio Table 126. CSL Recent Development Table 127. North America Topical Thrombin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 128. North America Topical Thrombin Sales by Country (2021-2026) & (tons) Table 129. North America Topical Thrombin Sales Market Share by Country (2021-2026) Table 130. North America Topical Thrombin Sales Forecast by Country (2027-2032) & (tons) Table 131. North America Topical Thrombin Sales Market Share Forecast by Country (2027-2032) Table 132. North America Topical Thrombin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Topical Thrombin Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Topical Thrombin Market Share by Country (2021-2026) Table 135. North America Topical Thrombin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Topical Thrombin Market Share Forecast by Country (2027-2032) Table 137. Europe Topical Thrombin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 138. Europe Topical Thrombin Sales by Country (2021-2026) & (tons) Table 139. Europe Topical Thrombin Sales Market Share by Country (2021-2026) Table 140. Europe Topical Thrombin Sales Forecast by Country (2027-2032) & (tons) Table 141. Europe Topical Thrombin Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Topical Thrombin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Topical Thrombin Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Topical Thrombin Market Share by Country (2021-2026) Table 145. Europe Topical Thrombin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Topical Thrombin Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Topical Thrombin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Topical Thrombin Sales by Country (2021-2026) & (tons) Table 149. Asia-Pacific Topical Thrombin Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Topical Thrombin Sales Forecast by Country (2027-2032) & (tons) Table 151. Asia-Pacific Topical Thrombin Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Topical Thrombin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Topical Thrombin Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Topical Thrombin Market Share by Country (2021-2026) Table 155. Asia-Pacific Topical Thrombin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Topical Thrombin Market Share Forecast by Country (2027-2032) Table 157. Latin America Topical Thrombin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 158. Latin America Topical Thrombin Sales by Country (2021-2026) & (tons) Table 159. Latin America Topical Thrombin Sales Market Share by Country (2021-2026) Table 160. Latin America Topical Thrombin Sales Forecast by Country (2027-2032) & (tons) Table 161. Latin America Topical Thrombin Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Topical Thrombin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Topical Thrombin Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Topical Thrombin Market Share by Country (2021-2026) Table 165. Latin America Topical Thrombin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Topical Thrombin Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Topical Thrombin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Topical Thrombin Sales by Country (2021-2026) & (tons) Table 169. Middle East and Africa Topical Thrombin Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Topical Thrombin Sales Forecast by Country (2027-2032) & (tons) Table 171. Middle East and Africa Topical Thrombin Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Topical Thrombin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Topical Thrombin Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Topical Thrombin Market Share by Country (2021-2026) Table 175. Middle East and Africa Topical Thrombin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Topical Thrombin Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Topical Thrombin Distributors List Table 180. Topical Thrombin Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Topical Thrombin Image Figure 2. Global Topical Thrombin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Thrombin Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Thrombin Sales (2021-2032) & (tons) Figure 5. Based Bovine Image Figure 6. Global Based Bovine Sales YoY Growth (2021-2032) & (tons) Figure 7. Based Human Image Figure 8. Global Based Human Sales YoY Growth (2021-2032) & (tons) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 11. Global Topical Thrombin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Topical Thrombin Market Share by Type 2025 VS 2032 Figure 13. North America Topical Thrombin Sales Market Share in Volume by Type in 2025 Figure 14. North America Topical Thrombin Sales Market Share in Value by Type in 2025 Figure 15. Europe Topical Thrombin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Topical Thrombin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Topical Thrombin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Topical Thrombin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Topical Thrombin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Topical Thrombin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Topical Thrombin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Topical Thrombin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Topical Thrombin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Academic and Research Institute Image Figure 26. Global Academic and Research Institute Sales YoY Growth (2021-2032) & (tons) Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (tons) Figure 29. Diagnostics & Clinics Image Figure 30. Global Diagnostics & Clinics Sales YoY Growth (2021-2032) & (tons) Figure 31. Global Topical Thrombin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Topical Thrombin Market Share by Application 2025 VS 2032 Figure 33. North America Topical Thrombin Sales Market Share in Volume by Application in 2025 Figure 34. North America Topical Thrombin Sales Market Share in Value by Application in 2025 Figure 35. Europe Topical Thrombin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Topical Thrombin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Topical Thrombin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Topical Thrombin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Topical Thrombin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Topical Thrombin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Topical Thrombin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Topical Thrombin Sales Market Share in Value by Application in 2025 Figure 43. North America Topical Thrombin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 44. North America Topical Thrombin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Topical Thrombin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Topical Thrombin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Topical Thrombin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. Europe Topical Thrombin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Topical Thrombin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Topical Thrombin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Topical Thrombin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Asia-Pacific Topical Thrombin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Topical Thrombin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Topical Thrombin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Topical Thrombin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Latin America Topical Thrombin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Topical Thrombin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Topical Thrombin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Topical Thrombin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 60. Middle East and Africa Topical Thrombin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Topical Thrombin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Topical Thrombin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Topical Thrombin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Topical Thrombin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Based Bovine
  • Based Human
  • Others
Applications
  • Academic and Research Institute
  • Hospitals
  • Diagnostics & Clinics
Companies covered
  • Takeda
  • Shanghai RAAS
  • Pfizer
  • Hualan Biological
  • Bayer
  • Omrix Biopharmaceuticals
  • Octapharma
  • Haematologic Technologies
  • Grifols
  • GE Healthcare
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Topical Thrombin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Topical Thrombin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Topical Thrombin Market by Type
  6. 1.3.1 Based Bovine
  7. 1.3.2 Based Human
  8. 1.3.3 Others
  9. 1.4 Global Topical Thrombin Market Size by Type
  10. 1.4.1 Global Topical Thrombin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Topical Thrombin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Topical Thrombin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Topical Thrombin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Topical Thrombin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Topical Thrombin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Topical Thrombin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Topical Thrombin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Topical Thrombin Industry Trends
  2. 2.2 Topical Thrombin Industry Drivers
  3. 2.3 Topical Thrombin Industry Opportunities and Challenges
  4. 2.4 Topical Thrombin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Topical Thrombin Revenue (2021-2026)
  2. 3.2 Global Top Players by Topical Thrombin Sales (2021-2026)
  3. 3.3 Global Top Players by Topical Thrombin Price (2021-2026)
  4. 3.4 Global Topical Thrombin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Topical Thrombin Major Company Production Sites & Headquarters
  6. 3.6 Global Topical Thrombin Company, Product Type & Application
  7. 3.7 Global Topical Thrombin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Topical Thrombin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Topical Thrombin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Topical Thrombin Tier 1, Tier 2, and Tier 3
4 Topical Thrombin Regional Status and Outlook
  1. 4.1 Global Topical Thrombin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Topical Thrombin Historic Market Size by Region
  3. 4.2.1 Global Topical Thrombin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Topical Thrombin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Topical Thrombin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Topical Thrombin Forecasted Market Size by Region
  7. 4.3.1 Global Topical Thrombin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Topical Thrombin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Topical Thrombin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Topical Thrombin by Application
  1. 5.1 Topical Thrombin Market by Application
  2. 5.1.1 Academic and Research Institute
  3. 5.1.2 Hospitals
  4. 5.1.3 Diagnostics & Clinics
  5. 5.2 Global Topical Thrombin Market Size by Application
  6. 5.2.1 Global Topical Thrombin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Topical Thrombin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Topical Thrombin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Topical Thrombin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Topical Thrombin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Topical Thrombin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Topical Thrombin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Topical Thrombin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Topical Thrombin Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Shanghai RAAS
  8. 6.2.1 Shanghai RAAS Company Information
  9. 6.2.2 Shanghai RAAS Business Overview
  10. 6.2.3 Shanghai RAAS Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai RAAS Topical Thrombin Product Portfolio
  12. 6.2.5 Shanghai RAAS Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Topical Thrombin Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Hualan Biological
  20. 6.4.1 Hualan Biological Company Information
  21. 6.4.2 Hualan Biological Business Overview
  22. 6.4.3 Hualan Biological Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Biological Topical Thrombin Product Portfolio
  24. 6.4.5 Hualan Biological Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Topical Thrombin Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Omrix Biopharmaceuticals
  32. 6.6.1 Omrix Biopharmaceuticals Company Information
  33. 6.6.2 Omrix Biopharmaceuticals Business Overview
  34. 6.6.3 Omrix Biopharmaceuticals Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Omrix Biopharmaceuticals Topical Thrombin Product Portfolio
  36. 6.6.5 Omrix Biopharmaceuticals Recent Developments
  37. 6.7 Octapharma
  38. 6.7.1 Octapharma Company Information
  39. 6.7.2 Octapharma Business Overview
  40. 6.7.3 Octapharma Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Octapharma Topical Thrombin Product Portfolio
  42. 6.7.5 Octapharma Recent Developments
  43. 6.8 Haematologic Technologies
  44. 6.8.1 Haematologic Technologies Company Information
  45. 6.8.2 Haematologic Technologies Business Overview
  46. 6.8.3 Haematologic Technologies Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Haematologic Technologies Topical Thrombin Product Portfolio
  48. 6.8.5 Haematologic Technologies Recent Developments
  49. 6.9 Grifols
  50. 6.9.1 Grifols Company Information
  51. 6.9.2 Grifols Business Overview
  52. 6.9.3 Grifols Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Grifols Topical Thrombin Product Portfolio
  54. 6.9.5 Grifols Recent Developments
  55. 6.10 GE Healthcare
  56. 6.10.1 GE Healthcare Company Information
  57. 6.10.2 GE Healthcare Business Overview
  58. 6.10.3 GE Healthcare Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GE Healthcare Topical Thrombin Product Portfolio
  60. 6.10.5 GE Healthcare Recent Developments
  61. 6.11 CSL
  62. 6.11.1 CSL Company Information
  63. 6.11.2 CSL Business Overview
  64. 6.11.3 CSL Topical Thrombin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSL Topical Thrombin Product Portfolio
  66. 6.11.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Topical Thrombin Sales by Country
  2. 7.1.1 North America Topical Thrombin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Topical Thrombin Sales by Country (2021-2026)
  4. 7.1.3 North America Topical Thrombin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Topical Thrombin Market Size by Country
  6. 7.2.1 North America Topical Thrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Topical Thrombin Market Size by Country (2021-2026)
  8. 7.2.3 North America Topical Thrombin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Topical Thrombin Sales by Country
  2. 8.1.1 Europe Topical Thrombin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Topical Thrombin Sales by Country (2021-2026)
  4. 8.1.3 Europe Topical Thrombin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Topical Thrombin Market Size by Country
  6. 8.2.1 Europe Topical Thrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Topical Thrombin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Topical Thrombin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Topical Thrombin Sales by Country
  2. 9.1.1 Asia-Pacific Topical Thrombin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Topical Thrombin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Topical Thrombin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Topical Thrombin Market Size by Country
  6. 9.2.1 Asia-Pacific Topical Thrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Topical Thrombin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Topical Thrombin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Topical Thrombin Sales by Country
  2. 10.1.1 South America Topical Thrombin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Topical Thrombin Sales by Country (2021-2026)
  4. 10.1.3 South America Topical Thrombin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Topical Thrombin Market Size by Country
  6. 10.2.1 South America Topical Thrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Topical Thrombin Market Size by Country (2021-2026)
  8. 10.2.3 South America Topical Thrombin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Topical Thrombin Sales by Country
  2. 11.1.1 Middle East and Africa Topical Thrombin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Topical Thrombin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Topical Thrombin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Topical Thrombin Market Size by Country
  6. 11.2.1 Middle East and Africa Topical Thrombin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Topical Thrombin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Topical Thrombin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Topical Thrombin Value Chain Analysis
  2. 12.1.1 Topical Thrombin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Topical Thrombin Production Mode & Process
  7. 12.2 Topical Thrombin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Topical Thrombin Distributors
  10. 12.2.3 Topical Thrombin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst